CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

MEDICURE INC

MCUJF
$19MMicro Cap

Next catalyst

Phase 3September 2027

Pyridoxal Phosphate

Pyridox(am)Ine 5'-Phosphate Oxidase Deficiency

Get an email about MCUJF's next catalysts

Track MEDICURE (MCUJF) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

No other upcoming event in our data.

Catalyst Timeline

1 upcoming, 0 past

Phase 3Next

Pyridoxal Phosphate Phase 3 Est. Readout (MEND-PNPO)

September 2027~Pyridoxal Phosphate15

Primary completion for Pyridoxal Phosphate trial (NCT04706013) in Pyridox(am)Ine 5'-Phosphate Oxidase Deficiency

Source

Market Overview

Stock performance and key metrics

NASDAQPharmaceutical PreparationsπŸ‡ΊπŸ‡ΈNorth AmericaWINNIPEG

Frequently asked questions

What is in MEDICURE INC's drug pipeline?β†’

CatalystAlert tracks 6 drug candidates in MEDICURE INC's (MCUJF) pipeline across Phase 3, Phase 2. Its lead program is Pyridoxal Phosphate (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is MEDICURE INC's next FDA catalyst?β†’

MEDICURE INC's (MCUJF) next tracked catalyst is a Phase 3 readout expected September 2027. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.

How do I track MCUJF biotech catalysts?β†’

Add MCUJF to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow MEDICURE INC's live catalyst calendar, drug pipeline and clinical-trial timeline on this page β€” sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply